Head and Neck Cancer Registry (LORHAN)

Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Inclusion Criteria:

• Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin
• Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
• Written informed consent

Exclusion Criteria:

• Registry participation does not exclude participation in clinical trials.
• Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.